Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Cancer Genetics Inc

(NASDAQ: CGIX)
Add to Portfolio
+0.01 (+11.11%)
as of Sep 17, 2019

Last 0.10
Change +0.01 (+11.11%)
Open 0.10
Prev. Close 0.09
Today's Range
0.09
0.10
52wk Range
0.09
1.30
Volume 3,840,600
Avg Volume 2,549,700
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
CGIX +11.11% -44.01% -90.52%
DJIA +0.13% +1.14% +4.02%
S&P 500 +0.26% +1.00% +4.05%

Key Statistics

Annual EPS -0.61
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 5,870
Weighted Alpha -91.45
Standard Deviation +1.25
Profit Margin N/A
Beta 1.58

Growth Rates

YTD -58.12%
1-Year -92.02%
3-Year -94.29%
5-Year -98.83%

Opinion

Sell Hold Buy

Recent Headlines

Cancer Genetics Reports Second Quarter 2019 Financial

GlobeNewswire via COMTEX - Tue Aug 20, 08:02AM EDT
Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced strategic, financial and operating results for the second quarter ended June 30, 2019.(full story)
CGIX: 0.10 (+0.01)

Cancer Genetics, Inc. Announces Strategic Transactions

GlobeNewswire via COMTEX - Mon Jul 15, 04:22PM EDT
Sale of BioPharma business to Interpace Diagnostics Group, Inc.(full story)
IDXG: 0.81 (-0.02), CGIX: 0.10 (+0.01)

Interpace Diagnostics Acquires Cancer Genetics'

GlobeNewswire via COMTEX - Mon Jul 15, 04:10PM EDT
Conference Call to be Held Tomorrow, Tuesday July 16, 2019 @ 8:30 am ET(full story)
NHLD: 2.42 (-0.18), IDXG: 0.81 (-0.02), CGIX: 0.10 (+0.01)

Innovate Biopharmaceuticals Expands Its Management

GlobeNewswire via COMTEX - Mon Jun 24, 07:04AM EDT
Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, today announced the appointment of Ed Sitar as its Chief F(full story)
INNT: 1.19 (+0.02), CGIX: 0.10 (+0.01)

Propanc Biopharma Appoints Dr. Ralf Brandt to its

BusinessWire via COMTEX - Mon May 06, 08:30AM EDT
Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that the Company has(full story)
PPCB: 0.8250 (-0.0050), CGIX: 0.10 (+0.01)